Literature DB >> 20540527

Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Zhenkun Zhu1, Xin Xu, Yanke Yu, Martin Graham, Mark E Prince, Thomas E Carey, Duxin Sun.   

Abstract

The small heat shock protein 27 (Hsp27) is a molecular chaperone that is involved in a variety of cellular functions in cancer cells. The purpose of this research is to study Hsp27 in vitro metastatic behaviors of head and neck squamous cell carcinoma cells (HNSCC). The expression of Hsp27 in primary and metastatic cell lines derived from the primary HNSCC and a synchronous lymph node metastasis in the same patient was determined using real-time PCR and Western blotting. Proliferation of the primary and metastatic HNSCC cell lines was evaluated using the MTS proliferation assay. Metastatic behavior was assessed using migration and invasion assays. SiRNA knockdown of Hsp27 was performed in the highly migratory metastatic HNSCC cell line. MTS assays showed that the primary (UM-SCC-22A) and metastatic (UM-SCC-22B) HNSCC have similar proliferation rates. However, UM-SCC-22B derived from the metastasis showed 2.3- to 3.6-fold higher migration ability and 2-fold higher invasion ability than UM-SCC-22A. Real-time PCR demonstrated that Hsp27 mRNA is 22.4-fold higher in metastatic UM-SCC-22B than primary UM-SCC-22A. Similarly, Western blotting showed that Hsp27 is rarely detectable in UM-SCC-22A whereas UM-SCC-22B expresses a 25-fold higher level of Hsp27 protein. SiRNA-mediated knockdown of Hsp27 in UM-SCC-22B reduced Hsp27 mRNA expression by nearly 6-fold and protein expression by 23-fold. Furthermore, siRNA knockdown of Hsp27 decreased metastatic behaviors of UM-SCC-22B by 3- to 4-fold in migration and 2-fold in cell invasion reducing cell invasion and migration to levels similar to the primary HNSCC UM-SCC-22A. These data indicate that Hsp27 may regulate metastatic potential of HNSCC cancer cells. Targeting Hsp27 may decrease metastasis in head and neck squamous cell cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540527      PMCID: PMC2914182          DOI: 10.1021/mp100073s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  47 in total

1.  Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus.

Authors:  K Kawanishi; H Shiozaki; Y Doki; I Sakita; M Inoue; M Yano; T Tsujinaka; A Shamma; M Monden
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.

Authors:  Xin Zhang; Zhuo Georgia Chen; Mi Sun Choe; Yan Lin; Shi-Yong Sun; H Samuel Wieand; Hyung Ju C Shin; Amy Chen; Fadlo R Khuri; Dong M Shin
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

3.  A study of heat shock protein 27 in endometrial carcinoma.

Authors:  J P Geisler; H E Geisler; J Tammela; G A Miller; M C Wiemann; Z Zhou
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

4.  Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues.

Authors:  Hai-Yan Song; Yin-Kun Liu; Ju-Tao Feng; Jie-Feng Cui; Zhi Dai; Li-Jun Zhang; Jiu-Xian Feng; Hua-Li Shen; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

5.  Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis.

Authors:  H J Arts; H Hollema; W Lemstra; P H Willemse; E G De Vries; H H Kampinga; A G Van der Zee
Journal:  Int J Cancer       Date:  1999-06-21       Impact factor: 7.396

6.  Heat shock protein 27 overexpression in breast cancer lymph node metastasis.

Authors:  F K Storm; D M Mahvi; K W Gilchrist
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

Review 7.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

8.  Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.

Authors:  C Garrido; A Fromentin; B Bonnotte; N Favre; M Moutet; A P Arrigo; P Mehlen; E Solary
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

Review 9.  Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.

Authors:  D R Ciocca; S Oesterreich; G C Chamness; W L McGuire; S A Fuqua
Journal:  J Natl Cancer Inst       Date:  1993-10-06       Impact factor: 13.506

10.  Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma.

Authors:  Hui Ye; Anxun Wang; Bao-Shiang Lee; Tianwei Yu; Shihu Sheng; Tingsheng Peng; Shen Hu; David L Crowe; Xiaofeng Zhou
Journal:  Cancer Genomics Proteomics       Date:  2008 Mar-Apr       Impact factor: 4.069

View more
  17 in total

1.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

2.  [Biology behavior of head and neck squamous cell cancer cells changes after knocking down heat shock protein 27].

Authors:  Zhen-Kun Zhu; Yu-Shang Wang; Xin Xu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

Review 3.  The heat shock proteins as targets for radiosensitization and chemosensitization in cancer.

Authors:  David M Guttmann; Constantinos Koumenis
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

4.  siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy.

Authors:  Paul Breen; Nicholas Joseph; Duska Separovic; Jacek Bielawski; Jason S Pierce; Eric VAN Buren; Tatyana I Gudz
Journal:  Anticancer Res       Date:  2012-07       Impact factor: 2.480

5.  Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.

Authors:  Paul Breen; Nicholas Joseph; Kyle Thompson; Jacqueline M Kraveka; Tatyana I Gudz; Li Li; Mehrdad Rahmaniyan; Jacek Bielawski; Jason S Pierce; Eric VAN Buren; Gaurav Bhatti; Duska Separovic
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

6.  Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.

Authors:  Oddbjørn Straume; Takeshi Shimamura; Michael J G Lampa; Julian Carretero; Anne M Øyan; Di Jia; Christa L Borgman; Margaret Soucheray; Sean R Downing; Sarah M Short; Soo-Young Kang; Souming Wang; Liang Chen; Karin Collett; Ingeborg Bachmann; Kwok-Kin Wong; Geoffrey I Shapiro; Karl Henning Kalland; Judah Folkman; Randolph S Watnick; Lars A Akslen; George N Naumov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-15       Impact factor: 11.205

7.  Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.

Authors:  Ah-Mee Park; Ikuo Tsunoda; Osamu Yoshie
Journal:  J Biol Chem       Date:  2018-08-30       Impact factor: 5.157

8.  Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.

Authors:  M Hirakawa; R Takimoto; F Tamura; M Yoshida; M Ono; K Murase; Y Sato; T Osuga; T Sato; S Iyama; K Miyanishi; K Takada; T Hayashi; M Kobune; J Kato
Journal:  Br J Cancer       Date:  2013-11-19       Impact factor: 7.640

9.  Targeting the testis-specific heat-shock protein 70-2 (HSP70-2) reduces cellular growth, migration, and invasion in renal cell carcinoma cells.

Authors:  Swarnendra Singh; Anil Suri
Journal:  Tumour Biol       Date:  2014-09-12

10.  Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.

Authors:  Wei Yuan; Chenguang Sui; Qian Liu; Wanyan Tang; Huaying An; Jie Ma
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.